Delivery Order SPE2DB25D3006-SPE2DB25FXKMW
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Belsomra 20 mg tablets (30-count) at a ceiling value of $1,088.22. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is classified as a child contract, meaning it derives from a larger indefinite delivery vehicle. AmerisourceBergen's place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Belsomra 20 mg tablets (30-count units) under a firm fixed-price contract valued at $1,488.99. This non-set-aside award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026 that supports global pharmaceutical supply to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 17, 2025, for the supply of Belsomra 10 mg tablets (30-count packaging). This contract, valued at $1,078.38, is classified as a firm fixed-price delivery order with an ultimate completion date of September 18, 2025. The award was made without a set-aside designation, indicating it was competitively awarded through open competition. AmerisourceBergen Drug Corp will perform...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Belsomra 20 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $1,181.89 and an ultimate completion date of July 23, 2025. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Belsomra 10mg tablets (30-count) under a firm fixed-price contract valued at $1,072.12. This competitively awarded, non-set-aside delivery order is set to complete by September 3, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- This delivery order, awarded June 30, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Belsomra 20 mg tablets (30-count units) with a ceiling value of $1,058.07. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,427.58 to AmerisourceBergen Drug Corp for Belsomra 10 mg tablets (30-count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price contract was awarded competitively with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Belsomra is a prescription medication used for sleep disorders, reflecting the pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,674.38 to supply 30 tablets of Belsomra 10 mg, a prescription medication used to treat insomnia. This firm fixed price contract was competitively awarded without any set-aside designation and has an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,185.57 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Belsomra 20 mg, a pharmaceutical product for treating insomnia. This competitively awarded, firm fixed-price contract was issued on September 11, 2025, with an ultimate completion date of September 12, 2025, and involves performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Belsomra 10 mg tablets. The firm-fixed-price contract has a ceiling value of $1,179.37 and a completion date of August 13, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support federal healthcare programs and services. The contract is not set-aside and is part of a larger Indefinite Delivery...